Eighteen attorneys from global law firm Greenberg Traurig, LLP have been named to 5280 magazine’s Denver’s Top Lawyers 2026 list, which recognizes the best attorneys in the Mile High City and beyond. 5280 magazine creates annual lists across various industries as resources for businesses and individuals in the Mile High City to find professionals with […]
The persistent corneal edema market is experiencing steady growth, driven by rising clinical awareness, improved postoperative monitoring, and growing focus on endothelial dysfunction-related complications. Additionally, the launch of emerging therapies such as AURN001 (Aurion Biotech/Alcon), EO2002 (Emmecell), TTHX1114 (Trefoil Therapeutics), and others will further drive the market forward. DelveInsight’s Persistent Corneal Edema Market Insights report
NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into pregnancy health. Nuvo Intl Group Inc, a leader in remote pregnancy monitoring and AI-enabled maternal-fetal care, today unveiled its pregnancy data solution built from real-world use of its FDA-cleared INVU(TM) pregnancy monitoring wearable technology. Through INVU(TM), Nuvo has assembled what
NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or
Primis Financial Corp. (NASDAQ: FRST) (the “Company”) today announced that it will release fourth quarter 2025 results after the market closes on Thursday, January 29, 2026. Following the release, the Company will host a conference call and audio webcast for analysts and investors at 10:00 a.m. Eastern Time on Friday, January 30, 2026. The webcast
Vancouver, British Columbia–(Newsfile Corp. – January 12, 2026) – Eastport Critical Metals Corp. (TSXV: EVI) (“Eastport” or the “Company“) is pleased to announce that it has engaged the services of Independent Trading Group (“ITG“) pursuant to an agreement effective December 18, 2026 (the “ITG Agreement“) to provide market-making services in accordance with TSX Venture Exchange (“TSXV“) policies.
Hong Kong, Hong Kong–(Newsfile Corp. – January 12, 2026) – Raging River Capital Limited (“Raging River“) announces that on November 19, 2025, AJN Resources Inc. (“AJN“) announced the closing of a non-brokered private placement (the “Private Placement“) of units (each, a “Unit“) in the capital of AJN with Raging River at a price of $0.10
Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr(TM) AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer’s Association recommended guidelines: brain-derived phosphorylated tau
In the news release, Shargo Manufacturing Brings 40+ Years of Engineering-Driven Air Distribution Innovation to AHR Expo 2026, issued 12-Jan-2026 by SHARGO MANUFACTURING INC. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Shargo Manufacturing Brings 40+ Years of